Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals
Patent
1985-05-23
1987-01-06
Nucker, Christine M.
Chemistry: analytical and immunological testing
Involving an insoluble carrier for immobilizing immunochemicals
436528, 436542, 436545, 436804, 436548, 436822, 530300, 530328, G01N 33543, G01N 33544
Patent
active
046346821
ABSTRACT:
Radioimmunossays for the quantitation of serum thymic factor (FTS), a thymic peptide hormone, are disclosed. Each assay employs an antibody specific for FTS, the monoclonal antibody or the antibody from the antiserum of a host animal; synthetic FTS or FTS analogue as the hormone standard; and a radiolabeled FTS analogue as the tracer. Also disclosed is a method of treating serum or other biological fluid prior to assay of FTS to remove interfering substances.
REFERENCES:
patent: 4002602 (1977-01-01), Goldstein
patent: 4055633 (1977-10-01), Goldstein
patent: 4124700 (1978-11-01), Goldstein
patent: 4167557 (1979-09-01), Goldstein
patent: 4264571 (1981-04-01), Goldstein et al.
Auger et al, Chemical Abstracts, vol. 97 (1982) #4358y.
Gastinel et al, Biochemical et Bio Physica Acta, vol. 684 (1982) pp. 117-126.
Erickson Bruce W.
Fok Kam-Fook
Incefy Genevieve S.
Ohga Kazuhiro
Nucker Christine M.
Sloan-Kettering Institute For Cancer
LandOfFree
Radioimmunoassays for the serum thymic factor (FTS) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioimmunoassays for the serum thymic factor (FTS), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioimmunoassays for the serum thymic factor (FTS) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-684084